Replimune (REPL) Current Assets (2018 - 2026)

Replimune (REPL) has 9 years of Current Assets data on file, last reported at $279.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 43.71% year-over-year to $279.1 million; the trailing twelve-month figure through Mar 2026 stood at $279.1 million (down 43.71% YoY), and the FY2026 full-year result was $279.1 million, down 43.71% from the prior year.
• Current Assets was little changed at $279.1 million in Q1 2026, from $280.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $624.0 million in Q4 2022 to a low of $279.1 million in Q1 2026.
• A 5-year average of $449.8 million and a median of $442.6 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 46.69% in 2023 and tumbled 48.8% in 2025, its largest moves.
• Tracing REPL's Current Assets over 5 years: stood at $624.0 million in 2022, then decreased by 23.21% to $479.2 million in 2023, then climbed by 14.28% to $547.6 million in 2024, then plunged by 48.8% to $280.4 million in 2025, then decreased by 0.44% to $279.1 million in 2026.
• Business Quant data shows REPL's Current Assets at $279.1 million in Q1 2026, $280.4 million in Q4 2025, and $333.7 million in Q3 2025.